﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Shahrekord University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Herbmed Pharmacology</JournalTitle>
      <Issn>2345-5004</Issn>
      <Volume>2</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>04</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The effect of silymarin on liver injury induced by Thioacetamide in rats</ArticleTitle>
    <FirstPage>29</FirstPage>
    <LastPage>33</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Najmeh</FirstName>
        <LastName>Kabiri</LastName>
      </Author>
      <Author>
        <FirstName>Mahboobeh</FirstName>
        <LastName>Ahangar-Darabi</LastName>
      </Author>
      <Author>
        <FirstName>Mahbubeh</FirstName>
        <LastName>Setorki</LastName>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Rafieian-kopaei</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Introduction: In this study the protective effects of Silymarin was investigated against thioacetamide (TAA) induced hepatotoxicity in rat. Methods: In an experimental study 24 male Wistar rats were designated in four equal groups as follows: Control group, the group treated with thioacetamide (TAA), Silymarin (400 mg/kg for 3 weeks) + TAA (400 mg/kg), TAA (400 mg/kg) + Silymarin (400 mg/kg for 3 weeks). The levels of serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) lactate dehydrogenase (LDH) and total bilirubin were measured to assess the hepatotoxicity and hepatoprotection. Results: TAA significantly increased AST, ALT, ALP, LDH and bilirubin. Treatment by Silymarin caused a significant reduction in serum levels of AST, ALT, ALP, LDH and bilirubin contents. Conclusion: The results indicate a protective effect for Silymarin against thioacetamide induced hepatotoxicity which might be due to its ability to block the bioactivity of thioacetamide.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Hepatoprotection</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Thioacetamide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Silymarin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Rat</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>